Agios Pharmaceuticals

Agios Pharmaceuticals

Employees:
290
Market Cap:
$2.77 billion
Revenue:
$69.95 million
5 Year Trend:
26.2%
Net Income:
$-212.78 million
NASDAQ:
AGIO

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

Agios Pharmaceuticals
Employees:
290
Market Cap:
$2.77 billion
Revenue:
$69.95 million
5 Year Trend:
26.2%
Net Income:
$-212.78 million
NASDAQ:
AGIO

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

19 jobs at Agios Pharmaceuticals

Jobs in